FDA Set to Decide on a New Non-Stimulant ADHD Drug for Children and Adults on July 24
FDA decides on centanafadine July 24, 2026 — a first-in-class non-stimulant ADHD drug for children, adolescents, and adults. Four Phase 3 trials support the application.
Medical Daily ·